Cargando…

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice

BACKGROUND: A major clinical issue affecting 10-40% of cancer patients treated with oxaliplatin is severe peripheral neuropathy with symptoms including cold sensitivity and neuropathic pain. Rat models have been used to describe the pathological features of oxaliplatin-induced peripheral neuropathy;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renn, Cynthia L, Carozzi, Valentina A, Rhee, Peter, Gallop, Danisha, Dorsey, Susan G, Cavaletti, Guido
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105941/ https://www.ncbi.nlm.nih.gov/pubmed/21521528 http://dx.doi.org/10.1186/1744-8069-7-29

Ejemplares similares

Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse
por: Carozzi, Valentina A., et al.
Publicado: (2013)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
por: Marmiroli, Paola, et al.
Publicado: (2017)

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
por: Cavaletti, Guido, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015)

Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity
por: Dionisi, Marianna, et al.
Publicado: (2023)

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
por: Fumagalli, Giulia, et al.
Publicado: (2021)

Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
por: Eldridge, Sandy, et al.
Publicado: (2021)

Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
por: Canta, Annalisa, et al.
Publicado: (2020)

Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
por: Canta, Annalisa, et al.
Publicado: (2022)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy
por: Pozzi, Eleonora, et al.
Publicado: (2023)

Toxicities of Therapeutic Agents Used in Medicine
por: Carozzi, Valentina Alda, et al.
Publicado: (2016)

Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
por: Ballarini, Elisa, et al.
Publicado: (2022)

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
por: Pfeiffer, Per, et al.
Publicado: (2022)

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
por: Pereira, A.F., et al.
Publicado: (2020)

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
por: Warncke, Urszula O., et al.
Publicado: (2021)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
por: Zhang, Yi, et al.
Publicado: (2021)

Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy
por: Delmotte, Jean-Baptiste, et al.
Publicado: (2018)

Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2023)

Oxaliplatin induces pH acidification in dorsal root ganglia neurons
por: Riva, Beatrice, et al.
Publicado: (2018)

Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Reply to a Comment Paper on the Published Paper by Canta, A. et al: “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity”—Antioxidants 2020, 9, 594
por: Canta, Annalisa, et al.
Publicado: (2020)

The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy
por: Azevedo, Maria Isabel, et al.
Publicado: (2013)

TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy
por: Marcotti, Aida, et al.
Publicado: (2022)

Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Choi, Seunghwan, et al.
Publicado: (2019)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Metformin protects from oxaliplatin induced peripheral neuropathy in rats
por: Martinez, N.W., et al.
Publicado: (2020)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
por: Egashira, Nobuaki
Publicado: (2021)

Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
por: Pozzi, Eleonora, et al.
Publicado: (2023)

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats
por: Meregalli, Cristina, et al.
Publicado: (2012)

Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
por: Chung, Kaitlin H., et al.
Publicado: (2022)

Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)()()
por: Karlsson, Jan Olof G., et al.
Publicado: (2017)

Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: a prospective cohort study
por: Gu, Zhancheng, et al.
Publicado: (2023)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021)

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
por: Lee, Jung Soo, et al.
Publicado: (2012)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rgl96605qeulgj7ljvov5r4noj